{"id":"https://openalex.org/W2551565005","doi":"https://doi.org/10.1016/j.tetlet.2016.11.092","title":"Improved and expanded one-pot, two-component Boulton-Katritzky syntheses of N\u2013N bond containing bicyclic heterocycles","display_name":"Improved and expanded one-pot, two-component Boulton-Katritzky syntheses of N\u2013N bond containing bicyclic heterocycles","publication_year":2016,"publication_date":"2016-11-23","ids":{"openalex":"https://openalex.org/W2551565005","doi":"https://doi.org/10.1016/j.tetlet.2016.11.092","mag":"2551565005"},"language":"en","primary_location":{"id":"doi:10.1016/j.tetlet.2016.11.092","doi":"https://doi.org/10.1016/j.tetlet.2016.11.092","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tetlet.2016.11.092","pdf_url":null,"source":{"id":"https://openalex.org/S133942674","display_name":"Tetrahedron Letters","issn_l":"0040-4039","issn":["0040-4039","1873-3581"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tetrahedron Letters","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026245761","display_name":"Kyle W. Knouse","orcid":"https://orcid.org/0000-0001-9688-0513","observed_orcids":["https://orcid.org/0000-0001-9688-0513"]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle W. Knouse","raw_affiliation_strings":["Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044725252","display_name":"Laura E. Ator","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura E. Ator","raw_affiliation_strings":["Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048566929","display_name":"Lauren E. Beausoleil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren E. Beausoleil","raw_affiliation_strings":["Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072632374","display_name":"Zachary J. Hauseman","orcid":"https://orcid.org/0000-0002-0260-2326","observed_orcids":["https://orcid.org/0000-0002-0260-2326"]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary J. Hauseman","raw_affiliation_strings":["Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019519248","display_name":"Rebecca L. Casaubon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca L. Casaubon","raw_affiliation_strings":["Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012330888","display_name":"Gregory R. Ott","orcid":"https://orcid.org/0009-0005-4843-6713","observed_orcids":["https://orcid.org/0009-0005-4843-6713"]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gregory R. Ott","raw_affiliation_strings":["Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Small Molecule Discovery, Discovery and Product Development, Teva Branded Pharmaceutical Products R&D, 145 Brandywine Parkway, West Chester, PA 19380, United States","institution_ids":["https://openalex.org/I4210139373"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5012330888"],"corresponding_institution_ids":["https://openalex.org/I4210139373"],"apc_list":{"value":3610,"currency":"USD","value_usd":3610},"apc_paid":null,"fwci":0.766,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.69070452,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"58","issue":"3","first_page":"202","last_page":"205"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10817","display_name":"Multicomponent Synthesis of Heterocycles","score":0.4115999937057495,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10817","display_name":"Multicomponent Synthesis of Heterocycles","score":0.4115999937057495,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13876","display_name":"Chemical synthesis and pharmacological studies","score":0.164900004863739,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12410","display_name":"Structural and Chemical Analysis of Organic and Inorganic Compounds","score":0.09380000084638596,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bicyclic-heterocycles","display_name":"bicyclic heterocycles","score":0.9070000052452087},{"id":"https://openalex.org/keywords/n-n-bond-formation","display_name":"N-N bond formation","score":0.6759999990463257},{"id":"https://openalex.org/keywords/pharmaceutical-heterocycles","display_name":"pharmaceutical heterocycles","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9250723123550415},{"id":"https://openalex.org/C24961977","wikidata":"https://www.wikidata.org/wiki/Q225972","display_name":"Bicyclic molecule","level":2,"score":0.883441150188446},{"id":"https://openalex.org/C40875361","wikidata":"https://www.wikidata.org/wiki/Q2356542","display_name":"Reagent","level":2,"score":0.7838594913482666},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5223590135574341},{"id":"https://openalex.org/C2776597398","wikidata":"https://www.wikidata.org/wiki/Q5954496","display_name":"Hydrazine (antidepressant)","level":2,"score":0.5075498819351196},{"id":"https://openalex.org/C2777682936","wikidata":"https://www.wikidata.org/wiki/Q408908","display_name":"Pyrazole","level":2,"score":0.48890820145606995},{"id":"https://openalex.org/C168167062","wikidata":"https://www.wikidata.org/wiki/Q1117970","display_name":"Component (thermodynamics)","level":2,"score":0.46445274353027344},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.40884503722190857},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.3826754689216614},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.0},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.tetlet.2016.11.092","doi":"https://doi.org/10.1016/j.tetlet.2016.11.092","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tetlet.2016.11.092","pdf_url":null,"source":{"id":"https://openalex.org/S133942674","display_name":"Tetrahedron Letters","issn_l":"0040-4039","issn":["0040-4039","1873-3581"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tetrahedron Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1592651207","https://openalex.org/W1993675254","https://openalex.org/W2014035904","https://openalex.org/W2030035423","https://openalex.org/W2041202493","https://openalex.org/W2045624262","https://openalex.org/W2047222830","https://openalex.org/W2092269205","https://openalex.org/W2109917682","https://openalex.org/W2110010969","https://openalex.org/W2136753139","https://openalex.org/W2169258376","https://openalex.org/W2949228035","https://openalex.org/W2950429791","https://openalex.org/W2950515695","https://openalex.org/W2950828025","https://openalex.org/W2952711115","https://openalex.org/W2953184707","https://openalex.org/W4241328952","https://openalex.org/W4246607066"],"related_works":["https://openalex.org/W2770388893","https://openalex.org/W2006687873","https://openalex.org/W3000607683","https://openalex.org/W2340569709","https://openalex.org/W2949262483","https://openalex.org/W2951807058","https://openalex.org/W2949750496","https://openalex.org/W2950786999","https://openalex.org/W2940167620","https://openalex.org/W2951177538"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3}],"updated_date":"2026-09-22T17:25:34.749102","created_date":"2016-11-30T00:00:00"}